Bluebird Bio reported $1.29B in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acceleron Pharma XLRN:US $ 10.52B 2.9B
Agios Pharmaceuticals AGIO:US $ 2.72B 672.75M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Applied Genetic Technologies AGTC:US $ 129.01M 38.16M
Arrowhead Research ARWR:US $ 6.51B 2.11B
Avrobio Inc AVRO:US $ 243.58M 127.72M
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Bluebird Bio BLUE:US $ 1.29B 865.55M
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Gilead Sciences GILD:US $ 87.58B 1.22B
Immunogen IMGN:US $ 1.18B 139.17M
Intercept Pharmaceuticals ICPT:US $ 493.04M 169.99M
IONIS PHARMACEUT IONS:US $ 4.73B 888.92M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Moderna Inc MRNA:US $ 155.35B 61B
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Novartis NOVN:VX 187.04B 20.99B
Pfizer PFE:US $ 241143.67M 21937.97M
Ptc Therapeutics PTCT:US $ 2.63B 355.33M
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Sangamo Biosciences SGMO:US $ 1.31B 412.77M
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
Vertex Pharmaceuticals VRTX:US $ 47.06B 5.14B
YTE INCY:US $ 15.19B 3.31B